Juno Therapeutics

Global biopharmaceutical company discovering, developing, and delivering innovative medicines

placeSeattle, Washington, United States calendar_todayFounded 2013 groups730 employees language junotherapeutics.com

Registered entities

Investor mix

16 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital956%
Private equity425%
Other / undisclosed319%
Coming soon